295 related articles for article (PubMed ID: 24374506)
21. Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease.
Marlatt MW; Potter MC; Bayer TA; van Praag H; Lucassen PJ
Curr Top Behav Neurosci; 2013; 15():313-40. PubMed ID: 23670818
[TBL] [Abstract][Full Text] [Related]
22. Impairments in spatial representations and rhythmic coordination of place cells in the 3xTg mouse model of Alzheimer's disease.
Mably AJ; Gereke BJ; Jones DT; Colgin LL
Hippocampus; 2017 Apr; 27(4):378-392. PubMed ID: 28032686
[TBL] [Abstract][Full Text] [Related]
23. Prolonged isolation stress accelerates the onset of Alzheimer's disease-related pathology in 5xFAD mice despite running wheels and environmental enrichment.
Peterman JL; White JD; Calcagno A; Hagen C; Quiring M; Paulhus K; Gurney T; Eimerbrink MJ; Curtis M; Boehm GW; Chumley MJ
Behav Brain Res; 2020 Feb; 379():112366. PubMed ID: 31743728
[TBL] [Abstract][Full Text] [Related]
24. [Morphological analysis of the hippocampal region associated with an innate behaviour task in the transgenic mouse model (3xTg-AD) for Alzheimer disease].
Orta-Salazar E; Feria-Velasco A; Medina-Aguirre GI; Díaz-Cintra S
Neurologia; 2013 Oct; 28(8):497-502. PubMed ID: 23972735
[TBL] [Abstract][Full Text] [Related]
25. Analysis of motor function in 6-month-old male and female 3xTg-AD mice.
Stover KR; Campbell MA; Van Winssen CM; Brown RE
Behav Brain Res; 2015 Mar; 281():16-23. PubMed ID: 25486177
[TBL] [Abstract][Full Text] [Related]
26. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
27. Propagation of Neuronal Damage to Embryonic Grafts Transplanted in the Hippocampus of Murine Models of Alzheimer's Disease.
Sadallah M; Labat-Gest V; Tempia F
Rejuvenation Res; 2015 Dec; 18(6):554-63. PubMed ID: 26540615
[TBL] [Abstract][Full Text] [Related]
28. Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study.
Noristani HN; Meadows RS; Olabarria M; Verkhratsky A; Rodríguez JJ
Cell Death Dis; 2011 Sep; 2(9):e210. PubMed ID: 21918544
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of the pore-forming K
Griffith CM; Xie MX; Qiu WY; Sharp AA; Ma C; Pan A; Yan XX; Patrylo PR
Neuroscience; 2016 Nov; 336():81-101. PubMed ID: 27586053
[TBL] [Abstract][Full Text] [Related]
30. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
[TBL] [Abstract][Full Text] [Related]
31. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
[TBL] [Abstract][Full Text] [Related]
32. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
33. Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy SA; Yang F; Irrizarry M; Hyman B; Saido TC; Hsiao K; Cole GM
Am J Pathol; 1998 Jan; 152(1):307-17. PubMed ID: 9422548
[TBL] [Abstract][Full Text] [Related]
34. Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse.
García-Mesa Y; Giménez-Llort L; López LC; Venegas C; Cristòfol R; Escames G; Acuña-Castroviejo D; Sanfeliu C
Neurobiol Aging; 2012 Jun; 33(6):1124.e13-29. PubMed ID: 22177720
[TBL] [Abstract][Full Text] [Related]
35. Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring.
Herring A; Donath A; Yarmolenko M; Uslar E; Conzen C; Kanakis D; Bosma C; Worm K; Paulus W; Keyvani K
FASEB J; 2012 Jan; 26(1):117-28. PubMed ID: 21948247
[TBL] [Abstract][Full Text] [Related]
36. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
37. Dysfunctional microglia:neuron interactions with significant female bias in a developmental gene x environment rodent model of Alzheimer's disease.
vonderEmbse AN; Hu Q; DeWitt JC
Int Immunopharmacol; 2019 Jun; 71():241-250. PubMed ID: 30927734
[TBL] [Abstract][Full Text] [Related]
38. Enrichment increases hippocampal neurogenesis independent of blood monocyte-derived microglia presence following high-dose total body irradiation.
Ruitenberg MJ; Wells J; Bartlett PF; Harvey AR; Vukovic J
Brain Res Bull; 2017 Jun; 132():150-159. PubMed ID: 28552674
[TBL] [Abstract][Full Text] [Related]
39. Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease.
Vandal M; White PJ; Chevrier G; Tremblay C; St-Amour I; Planel E; Marette A; Calon F
FASEB J; 2015 Oct; 29(10):4273-84. PubMed ID: 26108977
[TBL] [Abstract][Full Text] [Related]
40. Microglial pathology in Down syndrome.
Xue QS; Streit WJ
Acta Neuropathol; 2011 Oct; 122(4):455-66. PubMed ID: 21847625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
